Arcutis Biotherapeutics Inc (ARQT)
9.70
-0.23
(-2.32%)
USD |
NASDAQ |
Nov 15, 09:38
Arcutis Biotherapeutics Cash and Short Term Investments (Quarterly): 330.56M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 330.56M |
| June 30, 2024 | 362.44M |
| March 31, 2024 | 403.87M |
| December 31, 2023 | 271.86M |
| September 30, 2023 | 227.11M |
| June 30, 2023 | 268.67M |
| March 31, 2023 | 332.40M |
| December 31, 2022 | 409.59M |
| September 30, 2022 | 476.96M |
| June 30, 2022 | 282.17M |
| March 31, 2022 | 343.60M |
| Date | Value |
|---|---|
| December 31, 2021 | 387.06M |
| September 30, 2021 | 367.27M |
| June 30, 2021 | 409.36M |
| March 31, 2021 | 444.93M |
| December 31, 2020 | 284.44M |
| September 30, 2020 | 189.71M |
| June 30, 2020 | 223.98M |
| March 31, 2020 | 249.32M |
| December 31, 2019 | 101.26M |
| September 30, 2019 | 25.18M |
| December 31, 2018 | 50.94M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
101.26M
Minimum
Dec 2019
476.96M
Maximum
Sep 2022
318.33M
Average
331.48M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 278.37M |
| Biogen Inc | 1.699B |
| Vertex Pharmaceuticals Inc | 6.524B |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |